Innovative Therapies for Aging-Associated Diseases
ReGENE is committed to developing therapies that target the underlying mechanisms of aging. Our pipeline focuses on addressing aging-associated conditions, including Alzheimer’s disease, by targeting molecular pathways involved in the aging process.
Our Pipeline
We identified a node in a growth-promoting cascade, where suppression leads to strong rejuvenating effects in mice spanning across organ systems, aging-associated conditions, and metrics of health decline.
Targeting Type 3 Diabetes Mechanism of Alzheimer’s Disease
Our Alzheimer’s therapy targets the Type 3 Diabetes mechanism closely linked to the root cause of aging. We aim to offer a novel approach to treating one of the most challenging diseases of aging.
Groundbreaking Rejuvenation Therapy
Our treatment increased lifespan by 43 days and reduced frailty 3-fold in aged mice.
Control mice develop grey hair with aging Treated mice keep shiny black coats in old age
Healthspan Extension
Today we live longer than ever, but the last decades of our lives are associated with significant morbidities. Our treatment delayed the onset of the morbidity period by 149 days in mice. Similar compression of the sick span in humans will move the onset of morbidity period from 60 to 80 years of age.
Ready to Revolutionize Aging? Reach Out to Us!
We’d love to hear from you! Whether you have questions, need more information, or want to explore potential collaborations, feel free to reach out to us through our contact form. Our team is ready to assist and provide the support you need.